NCT06286891 Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients
| NCT ID | NCT06286891 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo General Hospital |
| Condition | Chronic Thromboembolic Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-02-29 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-02-29 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational and prospective study is to investigate changes in physical performance, lung function, respiratory and peripheral muscle strength in patients during the postoperative period following pulmonary endarterectomy (PET).
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Both genders * Elective pulmonary endarterectomy surgery * Absence of cognitive or peripheral motor impairment that prevents the performance of functional tests in the preoperative period. Exclusion Criteria: * Reoperation for any reason * Presence of cognitive or peripheral motor impairment that prevents the performance of functional tests in the postoperative period.
Contact & Investigator
Rafael M Ianotti, PT
PRINCIPAL INVESTIGATOR
Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Frequently Asked Questions
Who can join the NCT06286891 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Thromboembolic Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06286891 currently recruiting?
Yes, NCT06286891 is actively recruiting participants. Contact the research team at rafael.ianotti@hc.fm.usp.br for enrollment information.
Where is the NCT06286891 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT06286891 clinical trial?
NCT06286891 is sponsored by University of Sao Paulo General Hospital. The principal investigator is Rafael M Ianotti, PT at Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. The trial plans to enroll 50 participants.